Aureka Biotechnologies
PrivateLast Round
Series B
Aug 10, 2026
Total Funding Raised
$200M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Aureka Biotechnologies is a biotechnology company that develops a therapeutic discovery platform using generative AI and high-throughput screening to design and discover antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aureka Biotechnologies Comparables
Compare Aureka Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 88% | |
| Antiverse | 87% | |
| Infinimmune | 85% | |
Aureka Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 10, 2026 | ||||
| Series A Extension | Apr 28, 2026 | ||||
| Series A | Nov 10, 2025 | ||||
| Seed | Mar 1, 2024 | ||||
| Seed | Jun 25, 2023 |
Aureka Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| BioTrack Capital | Series A Extension |
| Boyuan Capital | Series A Extension |
| Highlight Capital | Series B |
| Granite Asia | Series B |
| 5Y Capital | Series A Extension, Series A |
| NRL Capital | Series A Extension, Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$100M round led by Granite Asia.
- Apr 28, 2026
Raised $35M led by HongShan (红杉中国)
Aureka Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aureka Biotechnologies's valuation, stock price, and market status.